Please read and agree to the terms and conditions of this site.
@tech.eu 1 year ago
Doctify, practitioner reviews you can bank on, now with another $10 million to spend
@xconomy.com 3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com 5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@thenextweb.com 6 years ago
How high can weed tech go? Pretty high if you ask Silicon Valley
@extremetech.com 7 years ago
Insane X-ray ‘superflares’ may have made Proxima b uninhabitable long ago
@techcrunch.com 8 years ago
The Marijuana Industry And Its First Crossroads